BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAF8. A total of 32 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2020 | $1,156,000 | +23.9% | 880,000 | 0.0% | 0.00% | – |
Q1 2020 | $933,000 | -2.4% | 880,000 | 0.0% | 0.00% | – |
Q4 2019 | $956,000 | -9.9% | 880,000 | -14.6% | 0.00% | – |
Q3 2019 | $1,061,000 | -33.8% | 1,030,000 | -28.0% | 0.00% | – |
Q2 2019 | $1,603,000 | -1.4% | 1,430,000 | 0.0% | 0.00% | – |
Q1 2019 | $1,625,000 | +30.4% | 1,430,000 | +27.7% | 0.00% | – |
Q4 2018 | $1,246,000 | -90.3% | 1,120,000 | -89.6% | 0.00% | -100.0% |
Q3 2018 | $12,878,000 | +1.3% | 10,735,000 | 0.0% | 0.00% | 0.0% |
Q2 2018 | $12,717,000 | -46.3% | 10,735,000 | -50.0% | 0.00% | -66.7% |
Q1 2018 | $23,660,000 | -11.2% | 21,485,000 | -4.5% | 0.00% | 0.0% |
Q4 2017 | $26,638,000 | -14.2% | 22,491,000 | -13.3% | 0.00% | -25.0% |
Q3 2017 | $31,041,000 | +0.6% | 25,935,000 | 0.0% | 0.00% | 0.0% |
Q2 2017 | $30,846,000 | +7.3% | 25,935,000 | +6.5% | 0.00% | 0.0% |
Q1 2017 | $28,760,000 | +0.7% | 24,360,000 | 0.0% | 0.00% | 0.0% |
Q4 2016 | $28,547,000 | -4.0% | 24,360,000 | +2.1% | 0.00% | 0.0% |
Q3 2016 | $29,750,000 | +7.8% | 23,860,000 | 0.0% | 0.00% | 0.0% |
Q2 2016 | $27,588,000 | +109.1% | 23,860,000 | +114.4% | 0.00% | +100.0% |
Q1 2016 | $13,196,000 | +1.5% | 11,130,000 | +14.4% | 0.00% | 0.0% |
Q4 2015 | $13,002,000 | +80.2% | 9,730,000 | +81.2% | 0.00% | +100.0% |
Q3 2015 | $7,216,000 | – | 5,370,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sonora Investment Management, LLC | 6,195,000 | $9,377,000 | 2.84% |
GUARDIAN LIFE INSURANCE CO OF AMERICA | 8,000,000 | $10,750,000 | 1.09% |
Man Investments (CH) AG | 1,100,000 | $1,482,000 | 0.73% |
ADVENT CAPITAL MANAGEMENT /DE/ | 22,554,000 | $30,444,000 | 0.47% |
SSI INVESTMENT MANAGEMENT LLC | 3,124,000 | $4,202,000 | 0.45% |
ARROWGRASS CAPITAL PARTNERS (US) LP | 20,000 | $22,373,000 | 0.42% |
Calamos Advisors LLC | 35,219,000 | $47,628,000 | 0.33% |
LINDEN ADVISORS LP | 2,500,000 | $3,370,000 | 0.23% |
Calamos Wealth Management LLC | 513,000 | $694,000 | 0.17% |
LOOMIS SAYLES & CO L P | 477,810 | $50,323,000 | 0.15% |